Connective Capital Management, LLC Biocept Inc Transaction History

Connective Capital Management, LLC

  • $55.6 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2024
SELL
$0.24 - $0.62 $25,987 - $67,133
-108,280 Closed
0 $0
Q4 2022

May 16, 2024
BUY
$0.47 - $0.89 $50,891 - $96,369
108,280 New
108,280 $57.4 Million

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Connective Capital Management, LLC Portfolio

Follow Connective Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connective Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connective Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email